Application of twin screw extrusion in the manufacture of cocrystals, part I: Four case studies

Pharmaceutics

Volumn 3, Issue 3, 2011, Pages 582-600

  Daurio, Dominick ^a   Medina, Cesar ^a   Saw, Robert ^a   Nagapudi, Karthik ^a   Alvarez Núñez, Fernando ^a  

^a AMGEN INC   (United States)

Author keywords

Cocrystals; Environmentally friendly; Green chemistry; Twin screw extrusion

Indexed keywords

CAFFEINE DERIVATIVE; CAFFEINE OXALIC ACID; CARBAMAZEPINE; CARBAMAZEPINE SACCHARIN; NICOTINAMIDE CINNAMIC ACID; NICOTINAMIDE DERIVATIVE; SOLVENT; THEOPHYLLINE CITRIC ACID; THEOPHYLLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; COCRYSTAL; CRYSTAL; CRYSTALLIZATION; DRUG MANUFACTURE; DRUG MIXTURE; GREEN CHEMISTRY; PROCESS TECHNOLOGY; TEMPERATURE; TWIN SCREW EXTRUSION;

EID: 80053001573     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics3030582     Document Type: Article

References (37)

1. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 2001, 46, 3-26.
2. Bond, A.D. What is a co-crystal? CrystEngComm 2007, 9, 833-834.
3. Desiraju, G.R. Crystal and co-crystal. CrystEngComm 2003, 5, 466-467.
4. Dunitz, J.D. Crystal and co-crystal. A second opinion. CrystEngComm 2003, 5, 506.
5. Bak, A.; Gore, A.; Yanez, E.; Stanton, M.; Tufekcic, S.; Syed, R.; Akrami, A.; Rose, M.; Surapaneni, S.; Bostick, T.; King, A.; Neervannan, S.; Ostovic, D.; Koparkar, A. The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics. J. Pharm. Sci. 2008, 97, 3942-3956.
6. Banerjee, R.; Bhatt, P.M.; Ravindra, N.V.; Desiraju, G.R. Saccharin Salts of Active Pharmaceutical Ingredients, Their Crystal Structures, and Increased Water Solubilities. Cryst. Growth Des. 2005, 5, 2299-2309.
7. Chen, A.M.; Ellison, M.E.; Peresypkin, A.; Wenslow, R.M.; Variankaval, N.; Savarin, C.G.; Natishan, T.K.; Mathre, D.J.; Dormer, P.G.; Euler, D.H.; Ball, R.G.; Ye, Z.; Wang, Y.; Santos, I. Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acid. Chem. Commun. (Cambridge UK) 2007, 419-421.
8. Childs, S.L.; Hardcastle, K.I. Cocrystals of Piroxicam with Carboxylic Acids. Cryst. Growth Des. 2007, 7, 1291-1304.
9. Good, D.J.; Rodriguez-Hornedo, N. Solubility Advantage of Pharmaceutical Cocrystals. Cryst. Growth Des. 2009, 9, 2252-2264.
10. McNamara, D.P.; Childs, S.L.; Giordano, J.; Iarriccio, A.; Cassidy, J.; Shet, M.S.; Mannion, R.; O'Donnell, E.; Park, A. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm. Res. 2006, 23, 1888-1897.
11. Remenar, J.F.; Morissette, S.L.; Peterson, M.L.; Moulton, B.; MacPhee, J.M.; Guzman, H.R.; Almarsson, O. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J. Am. Chem. Soc. 2003, 125, 8456-8457.
12. Variankaval, N.; Wenslow, R.; Murry, J.; Hartman, R.; Helmy, R.; Kwong, E.; Clas, S.-D.; Dalton, C.; Santos, I. Preparation and Solid-State Characterization of Nonstoichiometric Cocrystals of a Phosphodiesterase-IV Inhibitor and L-Tartaric Acid. Cryst. Growth Des. 2006, 6, 690-700.
13. Trask, A.V.; Motherwell, W.D.S.; Jones, W. Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration. Cryst. Growth Des. 2005, 5, 1013-1021.
14. Trask, A.V.; Motherwell, W.D.S.; Jones, W. Physical stability enhancement of theophylline via cocrystallization. Int. J. Pharm. 2006, 320, 114-123.
15. Karki, S.; Friscic, T.; Fabian, L.; Laity, P.R.; Day, G.M.; Jones, W. Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol. Adv. Mater. (Weinheim Ger.) 2009, 21, 3905-3909.
16. Sun, C.C.; Hou, H. Improving Mechanical Properties of Caffeine and Methyl Gallate Crystals by Cocrystallization. Cryst. Growth Des. 2008, 8, 1575-1579.
17. Alleso, M.; Velaga, S.; Alhalaweh, A.; Cornett, C.; Rasmussen, M.A.; van den Berg, F.; Lopez de Diego, H.; Rantanen, J. Near-Infrared Spectroscopy for Cocrystal Screening. A Comparative Study with Raman Spectroscopy. Anal. Chem. (Washington, DC, US) 2008, 80, 7755-7764.
18. Berry, D.J.; Seaton, C.C.; Clegg, W.; Harrington, R.W.; Coles, S.J.; Horton, P.N.; Hursthouse, M.B.; Storey, R.; Jones, W.; Friscic, T.; Blagden, N. Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients. Cryst. Growth Des. 2008, 8, 1697-1712.
19. Kojima, T.; Tsutsumi, S.; Yamamoto, K.; Ikeda, Y.; Moriwaki, T. High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate. Int. J. Pharm. 2010, 399, 52-59.
20. Lu, E.; Rodriguez-Hornedo, N.; Suryanarayanan, R. A rapid thermal method for cocrystal screening. CrystEngComm 2008, 10, 665-668.
21. Takata, N.; Shiraki, K.; Takano, R.; Hayashi, Y.; Terada, K. Cocrystal Screening of Stanolone and Mestanolone Using Slurry Crystallization. Cryst. Growth Des. 2008, 8, 3032-3037.
22. Zhang, G.G.Z.; Henry, R.F.; Borchardt, T.B.; Lou, X. Efficient co-crystal screening using solution-mediated phase transformation. J. Pharm. Sci. 2007, 96, 990-995.
23. Quehenberger, H. Organic molecular compounds and their polymorphism. Monatsh. Chem. 1949, 80, 595-606.
24. Tanaka, K.; Toda, F. Solvent-Free Organic Synthesis. Chem. Rev. (Washington, DC) 2000, 100, 1025-1074.
25. Friscic, T.; Trask, A.V.; Jones, W.; Motherwell, W.D.S. Screening for inclusion compounds and systematic construction of three-component solids by liquid-assisted grinding. Angew. Chem. Int. Ed. 2006, 45, 7546-7550.
26. Trask, A.V.; Motherwell, W.D.S.; Jones, W. Solvent-drop grinding: green polymorph control of cocrystallisation. Chem. Commun. (Cambridge UK) 2004, 890-891.
27. Chiarella, R.A.; Davey, R.J.; Peterson, M.L. Making Co-Crystals - The Utility of Ternary Phase Diagrams. Cryst. Growth Des. 2007, 7, 1223-1226.
28. Nehm, S.J.; Rodriguez-Spong, B.; Rodriguez-Hornedo, N. Phase Solubility Diagrams of Cocrystals Are Explained by Solubility Product and Solution Complexation. Cryst. Growth Des. 2006, 6, 592-600.
29. Rodriguez-Hornedo, N.; Nehm, S.J.; Seefeldt, K.F.; Pagan-Torres, Y.; Falkiewicz, C.J. Reaction Crystallization of Pharmaceutical Molecular Complexes. Mol. Pharm. 2006, 3, 362-367.
30. Ainouz, A.; Authelin, J.-R.; Billot, P.; Lieberman, H. Modeling and prediction of cocrystal phase diagrams. Int. J. Pharm. 2009, 374, 82-89.
31. Sheikh, A.Y.; Abd Rahim, S.; Hammond, R.B.; Roberts, K.J. Scalable solution cocrystallization: case of carbamazepine-nicotinamide I. CrystEngComm 2009, 11, 501-509.
32. Medina, C.; Daurio, D.; Nagapudi, K.; Alvarez-Nunez, F. Manufacture of pharmaceutical co-crystals using twin screw extrusion: a solvent-less and scalable process. J. Pharm. Sci. 2010, 99, 1693-1696.
33. Dhumal, R.S.; Kelly, A.L.; Paradkar, A.R. Development of solvent free continuous cocrystallisation technique. J. Pharm. Pharmacol. 2010, 62, 1418-1419.
34. Dhumal, R.S.; Kelly, A.L.; York, P.; Coates, P.D.; Paradkar, A. Cocrystallization and Simultaneous Agglomeration Using Hot Melt Extrusion. Pharm. Res. 2010, 27, 2725-2733.
35. Jayasankar, A.; Somwangthanaroj, A.; Shao, Z.J.; Rodriguez-Hornedo, N. Cocrystal Formation during Cogrinding and Storage is Mediated by Amorphous Phase. Pharm. Res. 2006, 23, 2381-2392.
36. Karki, S.; Friscic, T.; Jones, W.; Motherwell, W.D.S. Screening for Pharmaceutical Cocrystal Hydrates via Neat and Liquid-Assisted Grinding. Mol. Pharm. 2007, 4, 347-354.
37. Porter, W.W., III; Elie, S.C.; Matzger, A.J. Polymorphism in Carbamazepine Cocrystals. Cryst. Growth Des. 2008, 8, 14-16.